U.S. FTC Sees Red Flags In Studies Conducted Overseas To Support Supplement Claims
This article was originally published in PharmAsia News
The Federal Trade Commission is wary of studies conducted overseas used to substantiate claims for supplements, says Richard Cleland, assistant director of advertising practices
You may also be interested in...
The Dannon Co. will drop "exaggerated" health claims for two yogurt products, including claims in advertising with actress Jamie Lee Curtis, under a settlement with the Federal Trade Commission.
The Federal Trade Commission shifts away from "vanilla orders" and will issue more specific requirements in settlements with firms to provide clear guidance on compliance, advertising practices official Richard Cleland says.
A regular roundup of commercial stories appearing in Scrip’s sister publication PharmAsia News, whose multilingual team of regional experts provides authoritative business intelligence focused on the Asian marketplace. Full stories can be accessed by clicking on the story title (subscription required).